药物对比
Dulaglutide vs Insulin Icodec
比较每周一次的Dulaglutide（Trulicity）与Insulin Icodec（Awiqli）治疗糖尿病。GLP-1与基础胰岛素：获益、风险、体重和低血糖。
此页面暂无可用的对比维度。
临床背景
This comparison arises for type 2 diabetes patients considering once-weekly injectables after oral agents for better glycemic control.
结论
Dulaglutide is generally preferred for most type 2 diabetes cases due to added benefits, unless insulin therapy is specifically required.
全部药物对比